3 stories tagged with #biotech-stock, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Biotech Stock"
Viking Therapeutics Earnings: Q3 Maintenance Study Data A Potential Wildcard
Viking Therapeutics Phase 3 VANQUISH studies are fully enrolled, but pivotal data are not expected until late '27/early '28. Read why VKTX stock is a hold.…
Recursion: No Longer An AI 'Pet Science Project,' But Still A 'Sell'
Recursion Pharmaceuticals (RXRX) remains a 'Sell' as its ~$1.8B valuation is unsupported by clinical or commercial progress.…
Intellia Therapeutics And Wall Street Continue To Play Their D&D Game - Data And Doubt
Intellia Therapeutics faces a 'Data vs. Doubt' showdown after strong Phase 3 Lonvo-z results but a sharp stock drop. Click here to see why NTLA stock is still a Hold.…